Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus

被引：0
作者：
Jin Ah Jung
Kohei Kaku
Jae Hyeon Kim
Jung-Ryul Kim
Jae-Wook Ko
Soo-Youn Lee
Wooseong Huh
机构：
[1] Samsung Medical Center,Department of Clinical Pharmacology and Therapeutics
[2] Kawasaki Medical School,Department of Internal Medicine
[3] Sungkyunkwan University School of Medicine,Department of Internal Medicine, Samsung Medical Center
[4] Sungkyunkwan University,Department of Laboratory Medicine and Genetics, Samsung Medical Center
来源：
Advances in Therapy | 2013年 / 30卷
关键词：
Combination; Oral hypoglycemic agents; Mitiglinide; Sitagliptin; Type 2 diabetes, Phase 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1018 / 1029
页数：11
相关论文
共 50 条
[21]   Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus Mechanistic Links, Clinical Data, and Future Directions [J].
Vijayakumar, Shilpa ;
Vaduganathan, Muthiah ;
Butler, Javed .
CIRCULATION, 2018, 137 (10) :1060-1073
[22]   Comparison of efficacy of concomitant administration of mitiglinide with voglibose and double dose of mitiglinide in patients with type 2 diabetes mellitus [J].
Katsuno, Tomoyuki ;
Watanabe, Nobuaki ;
Nagai, Etsuko ;
Okazaki, Kazumi ;
Yokoyama, Ariko ;
Hamaguchi, Tomoya ;
Miyagawa, Jun-ichiro ;
Namba, Mitsuyoshi .
JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (03) :204-209
[23]   Add-on Treatment with Mitiglinide Improves Residual Postprandial Hyperglycemia in Type 2 Diabetic Patients Receiving the Combination Therapy with Insulin Glargine and Sitagliptin [J].
Murakami, Takaaki ;
Nambu, Takuo ;
Kato, Tomoko ;
Matsuda, Yuki ;
Yonemitsu, Shin ;
Muro, Seiji ;
Oki, Shogo .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 235 (04) :255-260
[24]   Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes [J].
Tremblay, A. J. ;
Lamarche, B. ;
Deacon, C. F. ;
Weisnagel, S. J. ;
Couture, P. .
DIABETES OBESITY & METABOLISM, 2011, 13 (04) :366-373
[25]   Mitiglinide: A Novel Agent for the Treatment of Type 2 Diabetes Mellitus [J].
Phillippe, Haley M. ;
Wargo, Kurt A. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (10) :1615-1623
[26]   Effects of sitagliptin on blood glucose, lipids, pancreatic β cell secretory function and insulin resistance in patients with type 2 diabetes mellitus [J].
Song Wenrong ;
Zhang Lei ;
Pan Zaoxia ;
Ding Mingyan ;
Luo Baochang ;
Li Qiong .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (01) :151-155
[27]   Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus [J].
Cho, Young Min ;
Koo, Bo Kyung ;
Son, Ho Young ;
Lee, KwangWoo ;
Son, Hyun Shik ;
Choi, Dong Seop ;
Kim, Bo Wan ;
Kim, Yong Ki ;
Lee, Moon Kyu ;
Lee, Hyun Chul ;
Min, Kyung Wan ;
Chung, Min Young ;
Baek, Hong Sun ;
Kim, Youngkun ;
Yoo, Hyung Joon ;
Park, Kyong Soo ;
Lee, Hong Kyu .
JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (04) :143-148
[28]   Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis [J].
Du, Qiang ;
Wu, Bo ;
Wang, Yan-Jun ;
Yang, Sheng ;
Zhao, Yue-Yang ;
Liang, Yuan-yuan .
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (11) :1487-1494
[29]   Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients [J].
Asti, Antonio ;
D'Alessandro, Alessandra ;
Zito, Francesco Paolo ;
Nardi, Salvatore ;
Sarnelli, Giovanni ;
Maresca, Giorgio ;
D'Alessandro, Giuseppe .
ITALIAN JOURNAL OF MEDICINE, 2016, 10 (01) :36-41
[30]   Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus [J].
Greg L. Plosker .
Drugs, 2014, 74 :223-242
12345